Cargando…

Development and Validation of a Prognostic Nomogram for Postoperative Recurrence-Free Survival of Ameloblastoma

PURPOSE: Ameloblastoma is a benign odontogenic neoplasm with a high local recurrence rate if the operation is not thorough. However, a useful clinical tool for the quantitative assessment of the prognosis and risk of postoperative recurrence of ameloblastoma has not yet been constructed. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yao-Cheng, Wang, Jun-Jie, Huang, Yun, Cai, Wei-Xin, Tao, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179736/ https://www.ncbi.nlm.nih.gov/pubmed/34103995 http://dx.doi.org/10.2147/CMAR.S307517

Ejemplares similares

Recurrent Ameloblastoma: Clinical Manifestation and Disease-Free Survival Rate
por: Hresko, Andrii, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Predicting Recurrence-Free Survival of Surgical Resected Retroperitoneal Liposarcoma
por: Zhuang, Aobo, et al.
Publicado: (2021)

Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer
por: Ding, Li, et al.
Publicado: (2022)

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
por: Ma, Lidi, et al.
Publicado: (2022)

Development and validation of a nomogram for predicting recurrence-free survival in endometrial cancer: a multicenter study
por: Li, Yinuo, et al.
Publicado: (2023)

A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma
por: Zhang, Zehan, et al.
Publicado: (2022)

Nomogram for Predicting Recurrence-Free Survival of Primary Localized Gastrointestinal Stromal Tumor
por: Ran, Pan, et al.
Publicado: (2023)

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
por: Lee, C K, et al.
Publicado: (2011)

Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model
por: Luo, Pan-Quan, et al.
Publicado: (2022)

Recurrence of Plexiform Ameloblastoma as Acanthomatous Ameloblastoma: A Rare Case Report
por: Bhuyan, Sanat Kumar, et al.
Publicado: (2019)

Treatment of recurrent mandibular ameloblastoma
por: INFANTE-COSSIO, PEDRO, et al.
Publicado: (2013)

Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation
por: Cheng, Yuan, et al.
Publicado: (2020)

Establishment and validation of a nomogram model for predicting postoperative recurrence-free survival in stage IA3 lung adenocarcinoma: a retrospective cohort study
por: Yu, Shaobin, et al.
Publicado: (2022)

Postoperative survival analysis and prognostic nomogram model for patients with portal hypertension
por: Zhang, Ya-Fei, et al.
Publicado: (2018)

Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors
por: Liu, Haotian, et al.
Publicado: (2021)

Developed and validated a prognostic nomogram for recurrence-free survival after complete surgical resection of local primary gastrointestinal stromal tumors based on deep learning
por: Chen, Tao, et al.
Publicado: (2018)

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
por: Zhang, Shu-Wen, et al.
Publicado: (2022)

Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management
por: Chen, Hengyu, et al.
Publicado: (2020)

Development and internal validation of nomograms for the prediction of postoperative survival of patients with grade 4 renal cell carcinoma (RCC)
por: Zhu, Jun, et al.
Publicado: (2020)

Recurrent unicystic ameloblastoma in a child
por: Ponniah, Irulandy
Publicado: (2011)

Recurrent Ameloblastoma: A Surgical Challenge
por: Aramanadka, Chithra, et al.
Publicado: (2018)

A methylomics‐associated nomogram predicts recurrence‐free survival of thyroid papillary carcinoma
por: Chen, Hengyu, et al.
Publicado: (2020)

Developing and validating a nomogram to predict myasthenia gravis exacerbation in patients with postoperative thymoma recurrence
por: Cheng, Biqi, et al.
Publicado: (2022)

Corrigendum: Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors
por: Liu, Haotian, et al.
Publicado: (2021)

Radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram
por: Shi, Shuguang, et al.
Publicado: (2022)

A Prognostic Nomogram Based on Immune Scores Predicts Postoperative Survival for Patients with Hepatocellular Carcinoma
por: Wang, Jukun, et al.
Publicado: (2020)

Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts
por: Lin, Yao, et al.
Publicado: (2020)

Incidence and Overall Survival of Malignant Ameloblastoma
por: Rizzitelli, Alexandra, et al.
Publicado: (2015)

A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma
por: Kong, Junjie, et al.
Publicado: (2019)

Validated Prognostic Nomograms for Patients With Parotid Carcinoma Predicting 2- and 5-Year Tumor Recurrence-Free Interval Probability
por: Peeperkorn, Sam, et al.
Publicado: (2020)

Development and validation of a nomogram based on preoperative variables for predicting recurrence‐free survival in stage IA lung adenocarcinoma
por: Xu, Jiaxi, et al.
Publicado: (2023)

Recurrent Unicystic Ameloblastoma of the Infratemporal and Temporal Fossa
por: Sharma, Sunil, et al.
Publicado: (2009)

Subepithelial Hyalinisation Predicts Recurrence of Unicystic Ameloblastomas
por: Augustine, Dominic, et al.
Publicado: (2022)

Carbon ion radiotherapy for recurrent ameloblastoma: A case report
por: Zhang, Yihe, et al.
Publicado: (2022)

Recurrence and cancerization of ameloblastoma: multivariate analysis of 87 recurrent craniofacial ameloblastoma to assess risk factors associated with early recurrence and secondary ameloblastic carcinoma
por: Yang, Rong, et al.
Publicado: (2017)

A prognostic nomogram for predicting recurrence-free survival of stage I–III colon cancer based on immune-infiltrating Treg-related genes
por: Xu, Longwen, et al.
Publicado: (2023)

A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma
por: Wang, Tao, et al.
Publicado: (2021)

Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
por: Li, Shuaishuai, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Predicting Survival in Gallbladder Cancer Patients With Recurrence After Surgery
por: Chen, Mingyu, et al.
Publicado: (2021)

Development and validation of nomograms to recurrence and survival in patients with early-stage cervical adenocarcinoma
por: Wang, Xintao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jm227stodeuboobatv6o7ua802